Global Alzheimer Drugs Market: An AnalysisKoncept AnalyticsMarch 1, 2009 25 Pages - SKU: KOAN2154519 |
| Countries covered: Global The Alzheimer’s disease (AD) diagnosis and therapy market is expanding with increasing number of cases worldwide. The current scenario shows bright outlook for diagnosis market. As early diagnosis of AD is not possible, there is a strong need of an early detection technique. United States, Europe and Japan are the three major markets for the treatment of AD. In China, the diagnosis and drug treatment of Alzheimer’s disease is extremely low, which represents a potential opportunity for market players. The worldwide Alzheimer disease market is led by sales of Eisai/Pfizer and Aricept. Eisai/Pfizer’s Aricept (donepezil) and Forest pharmaceutical’s Namenda (memantine) are the market leaders in the United States. After cardiovascular diseases and cancer, AD is the third largest market in the world in terms of cost of treatment of the disease. Aging population is a major cause of increasing number of Alzheimer patients and driving AD diagnosis and treatment market. Urbanization also contributes to the growing AD market. The unmet clinical needs are driving competitors to focus on R&D which ultimately leads to new product introduction and helps in market growth. The present report analyzes Alzheimer’s disease treatment and diagnosis market and discusses major drugs being used for the treatment of AD in United States, Japan and China. It analyses major growth drivers and opportunities present in the market. The report also discusses competition prevailing in the industry and an overview of the leading companies and their business strategies. The section on market forecast helps market players to develop business strategies accordingly. |
More Global Alzheimer's Disease Reports
Disease and Therapy Review: Alzheimer's Disease by
Timely Data Resources, Inc.
The Alzheimer Disease Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers for major countries worldwide, ...
Neurodegenerative Drugs by
Global Industry Analysts
This report analyzes the worldwide markets for Neurodegenerative Drugs in US$ Million by the following disease types: Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis, Amyotrophic Lateral ...
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets by
BCC Research
THIS REPORT:
Focus on the background and the current state of disease-modifying and treatment-of-symptoms therapeutics, and the diagnostics global market segments
Provide global ...
World Neurodegenerative Diseases Market 2009-2024 by
Visiongain
The ageing of the baby-boom generation, combined with new and emerging treatments for neurodegenerative disorders - including multiple sclerosis, Alzheimer's disease and Parkinson's disease - ...
The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends) by
Kalorama Information
Alzheimer’s Disease is the most common cause of dementia, constituting 60% to 70% of all cases, and the risk with the disease doubles every 5 ...
See all reports like this >>
Related Markets
Alzheimer's Disease Reports
- Alzheimer's Disease Global Clinical Trials Review, H2, 2011
- Prescribing Influences: Alzheimer's Disease - Alleviating symptoms remains the goal for prescribers
- Advances in Alzheimer's Disease Drug Discovery
- The Neurotechnology Industry 2011 Report
- The 10th International Conference on Alzheimer's and Parkinson's Diseases: Post-Conference Review and Analysis
